Daridorexant for Alcohol Use Disorder

NCT07532252 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder

Interventions

DRUG: Daridorexant 50 mg
OTHER: Placebo

Sponsor

Johns Hopkins University

Collaborators

[object Object]
[object Object]